Home > Analytics > AKUMS DRUGS & PHARMACEUTICALS

AKUMS DRUGS & PHARMACEUTICALS
Intrinsic Value | Fundamental Analysis

BOM : 544222     NSE : AKUMS    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Jul 18,2025
Price(EOD): ₹ 553.25
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 8,708.16 Cr
Value of ₹ 1 Lac invested in AKUMS DRUGS & PHARMACEUTICALS
on Aug 06,2024 (price: ₹ 796.35)

₹ 1 L

₹ 0.69 L

1W : 0.3% 1M : 2.4% 1Y : NA
COMMUNITY POLL
for AKUMS DRUGS & PHARMACEUTICALS
Please provide your vote to see the results
AKUMS DRUGS & PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Industry Peers & Returns1W1M1Y
AKUMS DRUGS & PHARMACEUTICALS 0.3% 2.4% NA
SUN PHARMACEUTICAL INDUSTRIES 0.7% 2.8% 7.9%
DIVIS LABORATORIES -0.8% 3.7% 48.6%
CIPLA -0.2% -0.1% -1.9%
TORRENT PHARMACEUTICALS 3.4% 11.2% 17.9%
DR REDDYS LABORATORIES 0.6% -5.2% -4.9%
MANKIND PHARMA -1.7% 14.2% 24.9%
ZYDUS LIFESCIENCES 0.7% 2.7% -17.1%
LUPIN 0.3% -0.1% 6%

FUNDAMENTAL ANALYSIS OF AKUMS DRUGS & PHARMACEUTICALS

 
Fundamentals Score
[ Q(TTM): Mar2025, Y: Mar2025
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF AKUMS DRUGS & PHARMACEUTICALS

 
Valuation Score
[As on : Jul 18,2025 ]

Ratio Consolidated
P/E
P/B
P/S
25.33
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 343.78 Cr
[Latest Qtr - Mar2025 - Consolidated Results ]

2.86
P/B Calculated based on Book Value of Rs 3,047.01 Cr
[Latest Year - Mar2025 - Consolidated Results ]

2.11
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 4,118.16 Cr
[Latest Qtr - Mar2025 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 16% undervalued companies ! Discover More →

FAIR VALUE OF AKUMS DRUGS & PHARMACEUTICALS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
NA
25753%
-

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF AKUMS DRUGS & PHARMACEUTICALS



AKUMS DRUGS & PHARMACEUTICALS vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF AKUMS DRUGS & PHARMACEUTICALS

Year Debt/Equity ratio
Standalone Consolidated
2025
2024
2023
Avg_3yrs
0
1.57
0.47
0.68
0
0.69
0.75
0.48
[Last Annual Data : Mar2025]
Financial Ratios →

PLEDGED PROMOTER SHARES OF AKUMS DRUGS & PHARMACEUTICALS

Pledged Promoter Shares
0 %
As on : Jun2025

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF AKUMS DRUGS & PHARMACEUTICALS

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
4.47%
-22.62%
-17.48%
125.61%
11.79%
3041.95%
328.5%
479.06%
QtrlyTrend
4
Latest Qtr: Mar2025
Quarterly Result Analysis →


AKUMS DRUGS & PHARMACEUTICALS related INDICES

BSE Indices1W1M1Y
BSE ALLCAP 6.4% 8.9% 7.5%
BSE MIDSMALLCAP 4.7% 9% 8.4%
BSE HEALTHCARE 1.8% 4.6% 16.4%
BSE SMALLCAP 1.5% 4.3% 2.1%
BSE IPO 0.9% 7.1% -3.8%
NSE Indices1W1M1Y
NIFTY SMALLCAP 250 1.5% 4.5% 0.9%
NIFTY IPO INDEX 1.4% 6.3% NA
NIFTY MIDSMALLCAP 400 1.2% 3.1% 1.6%
NIFTY 500 EQUAL WEIGHT 1.1% 3.5% -0.1%
NIFTY500 LARGEMIDSMALL EQUAL-CAP WEIGHTED INDEX 0.7% 2.6% 1.1%

You may also like the below Video Courses


FAQ about AKUMS DRUGS & PHARMACEUTICALS


Is AKUMS DRUGS & PHARMACEUTICALS good for long term investment?

As on Jul 18,2025, the Fundamentals of AKUMS DRUGS & PHARMACEUTICALS look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of AKUMS DRUGS & PHARMACEUTICALS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is AKUMS DRUGS & PHARMACEUTICALS UnderValued or OverValued?

As on Jul 18,2025, AKUMS DRUGS & PHARMACEUTICALS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of AKUMS DRUGS & PHARMACEUTICALS ?

As on Jul 18,2025, the Intrinsic Value of AKUMS DRUGS & PHARMACEUTICALS is Rs. 2.14 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. -8.74
Fair Value [Median EV / Sales Model] : Rs. 2.14
Fair Value [Median Price / Sales Model] : Rs. 0.00
Estimated Median Fair Value of AKUMS DRUGS & PHARMACEUTICALS : Rs. 2.14

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is AKUMS DRUGS & PHARMACEUTICALS trading at a Premium or Discount?

As on Jul 18,2025, AKUMS DRUGS & PHARMACEUTICALS is trading at a Premium of 25715% based on the estimates of Median Intrinsic Value!